Biotech News
-
FendX Technologies Inc. to Present at the Emerging Growth Conference on October 4, 2023
FendX Technologies Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time,…
-
Hemostemix Announces Private Placement
September 27, 2023 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce a…
-
Cardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare Conference
September 26, 2023 (Source) — Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences…
-
FendX Engages Independent Trading Group (ITG), Inc. for Market Making Services and Engages Longtable Capital Partners for IR Services
September 25, 2023 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”), a…
-
Zentek to Showcase ZenGUARD(TM) for HVAC at BUILDEX Alberta 2023
September 25, 2023 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company…
-
Zentek Announces Annual General Meeting on Thursday October 5th, 2023, at the Delta Hotel in Guelph, Ontario
September 21, 2023 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization…
-
Cardiol Therapeutics Announces All Collaborating Clinical Research Centers Now Initiated and Eligible to Enroll Patients in ARCHER, a Phase II Trial of CardiolRx(TM) for the Treatment of Acute Myocarditis
Recruitment Accelerating and Full Patient Enrollment Anticipated to be Completed During Q3 2024, up to Six Months Ahead…
-
Hemostemix Announces New Publication: How NCP-01 Supports Brain Computer Interfaces
September 12, 2023 (Source) — Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce its…
-
Zentek’s ZenGUARD(TM)-Enhanced Filters Demonstrate Robust Return on Investment in ParticleOne Study
September 11, 2023 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization…
-
Zentek Announces Breakthrough Results in Viral Filtration Efficiency with Dust Loading
September 06, 2023 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization…
